Articles
Filter by Topic
- People (330) Apply People filter
- Reproduction (241) Apply Reproduction filter
- Publications (186) Apply Publications filter
- Experiments (129) Apply Experiments filter
- Legal (114) Apply Legal filter
- Technologies (91) Apply Technologies filter
- Theories (78) Apply Theories filter
- Processes (75) Apply Processes filter
- Disorders (73) Apply Disorders filter
- Organizations (59) Apply Organizations filter
- Outreach (49) Apply Outreach filter
- Ethics (40) Apply Ethics filter
- Religion (26) Apply Religion filter
- Organisms (12) Apply Organisms filter
- Reproductive Health Arizona (11) Apply Reproductive Health Arizona filter
- RHAZ (4) Apply RHAZ filter
- Places (3) Apply Places filter
- DNA (1) Apply DNA filter
- Publication (1) Apply Publication filter
- Technology (1) Apply Technology filter
Filter by Format
- (-) Remove Articles filter Articles
“Delayed Breastfeeding Initiation Increases Risk of Neonatal Mortality” (2006), by Karen Edmond Charles Zandoh, Maria Quigley, Seeba Amenga-Etego, Seth Oqusi-Agyei, and Betty Kirkwood
By Alexis Darby
In March 2006, scientists from Ghana and the UK Karen Edmond, Charles Zandoh, Maria Quigley, Seeba Amenga-Etego, Seth Oqusi-Agyei, and Betty Kirkwood published their findings that early, consistent breastfeeding habits for mothers in Ghana resulted in better survival outcomes for their infants. The authors communicated those results in the paper “Delayed Breastfeeding Initiation Increases Risk of Neonatal Mortality,” or “Delayed Breastfeeding,” published in The American Academy of Pediatrics.
Format: Articles
Subject: Publications
Genetics and IVF Institute, GIVF
By Alysse Blight
In 1984, human genetics and reproduction researcher and physician Joseph D. Schulman founded the Genetics and IVF Institute, an international organization that provides infertility treatment and genetic services to patients. IVF stands for in vitro fertilization, an infertility treatment in which a female egg is fertilized by male sperm outside of the female body. GIVF is headquartered in Fairfax, Virginia, in association with Inova Health System, formerly called the Fairfax Hospital Association, one of the largest regional hospital systems in the United States.
Format: Articles
Subject: Organizations, Reproduction
40 Weeks (2014)
By Jessica Pollesche
In 2014, Big Belli, a media and social networking brand, released a documentary called 40 Weeks online. The documentary, directed by Christopher Henze, followed multiple women during their pregnancies. The film predominantly features three women, though it includes the stories of many. Throughout the film, women detail their accounts of the physical and emotional changes that occur during pregnancy.
Format: Articles
Subject: Publications
“Guideline for the Study and Evaluation of Gender Differences in the Clinical Evaluation of Drugs” (July 1993), by the United States Food and Drug Administration
By Caroline Meek
The US Food and Drug Administration, or FDA, published the “Guideline for the Study and Evaluation of Gender Differences in the Clinical Evaluation of Drugs,” henceforth “Study of Gender Differences,” in July 1993. The document defined acceptable practices for investigators studying new drugs. Prior to 1993, investigators excluded most women from clinical trials because in 1977, the FDA recommended that anyone who could possibly become pregnant be excluded from early phase drug research to minimize risk to a potential fetus.
Format: Articles
Subject: Publications
Jesse Bennett (1769–1842)
By Claire Grayson
Jesse Bennett, sometimes spelled Bennet, practiced medicine in the US during the late eighteenth century and performed one of the first successful cesarean operations, later called cesarean sections, in 1794. Following complications during his wife’s childbirth, Bennett made an incision through her lower abdomen and uterus to deliver their infant. Bennett’s biographers report that his operation was the first cesarean section where both the pregnant woman and the infant survived.
Format: Articles
Subject: People
De Monstruorum Causis, Natura et Differentiis (On the Reasons, Nature and Differences of Monsters) (1616), by Fortunio Liceti
By Anna Guerrero
In 1616 in Padua, Italy, Fortunio Liceti, a professor of natural philosophy and medicine, wrote and published the first edition of De Monstruorum Causis, Natura et Differentiis (On the Reasons, Nature, and Differences of Monsters), hereafter De monstruorum. In De monstruorum, Liceti chronologically documented cases of human and animal monsters from antiquity to the seventeenth century. During the seventeenth century, many people considered such monsters as frightening signs of evil cursed by spiritual or supernatural entities.
Format: Articles
Subject: Theories
US Food and Drug Administration’s Requirements on Content and Format for Labeling for Human Prescription Drugs Rule (1979)
By Caroline Meek
Format: Articles
Subject: Legal
"Effects of Social Support During Parturition on Maternal and Infant Morbidity” (1986), by Marshall Klaus, John Kennell, Steven Robertson, and Roberto Sosa
By Alexis Darby
Format: Articles
Subject: Publications
Matthew Howard Kaufman (1942–2013)
By Lance Villarreal
Matthew Kaufman was a professor of anatomy at the University of Edinburgh, in Edinburgh, UK, who specialized in mouse anatomy, development, and embryology during the late twentieth century. According to the The Herald, he was the first, alongside his colleague Martin Evans, to isolate and culture embryonic stem cells. Researchers initially called those cells Evans-Kaufman cells. In 1992, Kaufman published The Atlas of Mouse Development, a book that included photographs of mice development and mice organs over time.
Format: Articles
Subject: People
Physician Labeling Rule (2006)
By Caroline Meek
In 2006, the United States Food and Drug Administration, or FDA, published the “Requirements on Content and Format of Labeling for Human Prescription Drug and Biological Products,” also called the Physician Labeling Rule, to improve the safety and efficacy of prescription drugs and drug products. Within the Physician Labeling Rule, the FDA includes a section titled “Use in Specific Populations” or Section 8, which refers to drugs used by pregnant women, lactating women, and people of reproductive capacity.
Format: Articles
Subject: Legal